APA (7th ed.) Citation

Jenkins, H., Sakurai, Y., Nishimura, A., Okamoto, H., Hibberd, M., Jenkins, R., . . . Warrington, S. (2015). Randomised clinical trial: Safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects. Alimentary pharmacology & therapeutics, 41(7), 636-648. https://doi.org/10.1111/apt.13121

Chicago Style (17th ed.) Citation

Jenkins, H., et al. "Randomised Clinical Trial: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeated Doses of TAK‐438 (vonoprazan), a Novel Potassium‐competitive Acid Blocker, in Healthy Male Subjects." Alimentary Pharmacology & Therapeutics 41, no. 7 (2015): 636-648. https://doi.org/10.1111/apt.13121.

MLA (9th ed.) Citation

Jenkins, H., et al. "Randomised Clinical Trial: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeated Doses of TAK‐438 (vonoprazan), a Novel Potassium‐competitive Acid Blocker, in Healthy Male Subjects." Alimentary Pharmacology & Therapeutics, vol. 41, no. 7, 2015, pp. 636-648, https://doi.org/10.1111/apt.13121.